CAFTA Could Hurt Generic Drug Exports To Central America, GPhA Says
Executive Summary
The Dominican Republic-Central American Free Trade Agreement threatens the generic drug industry because it lacks Waxman-Hatch-type access provisions to balance intellectual property protections, the Generic Pharmaceutical Association says
You may also be interested in...
Importation Limits In Future Trade Agreements Prevented Under Vitter Bill
Pharmaceutical importation prohibitions in future U.S. trade agreements would be forbidden under a bill co-sponsored by Sens. David Vitter (R-La.) and Debbie Stabenow (D-Mich.)
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011